Kleniewski J, Donaldson V H
Department of Pediatrics and Medicine, University of Cincinnati College of Medicine, OH 45229-2899.
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):198-202. doi: 10.1073/pnas.90.1.198.
Human umbilical vein endothelial cells (HUVECs) produce a property that impairs the generation of coagulant and amidolytic activity initiated when normal human plasma is exposed to glass. This inhibitory property blocks the adsorption of Hageman factor (factor XII) to glass, thereby preventing the activation of Hageman factor, but does not impair the coagulant or amidolytic activity of already activated Hageman factor (factor XIIa). This property in HUVEC lysates could be neutralized by a purified preparation of Hageman factor but not by purified prekallikrein or high molecular mass kininogen. A partially purified inhibitory fraction from cell lysates exhibited a single homogeneous band in SDS/PAGE of approximately 22.5 kDa. Inhibitory activity was also found in concentrates of conditioned media from HUVECs, which also impaired the binding of Hageman factor to a surface; it may not be identical with that found in cell lysates.
人脐静脉内皮细胞(HUVECs)产生一种特性,该特性会损害正常人血浆暴露于玻璃时引发的凝血和酰胺水解活性的产生。这种抑制特性会阻止哈格曼因子(因子XII)吸附到玻璃上,从而防止哈格曼因子的激活,但不会损害已激活的哈格曼因子(因子XIIa)的凝血或酰胺水解活性。HUVEC裂解物中的这种特性可以被纯化的哈格曼因子制剂中和,但不能被纯化的前激肽释放酶或高分子量激肽原中和。来自细胞裂解物的部分纯化抑制级分在SDS/PAGE中呈现出一条约22.5 kDa的单一均一谱带。在HUVECs条件培养基的浓缩物中也发现了抑制活性,其同样会损害哈格曼因子与表面的结合;它可能与细胞裂解物中的抑制活性不同。